Tocilizumab ist zur Behandlung des Primären Sjögren Syndroms ungeeignet

Tocilizumab ist zur Behandlung des Primären Sjögren Syndroms ungeeignet

No Author Found
Aktuelle Rheumatologie 2021 Vol. 46 pp. 435-435
29
noauthorfound2021tocilizumabaktuelle

Citation

ID: 279636
Ref Key: noauthorfound2021tocilizumabaktuelle
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
279636
Unique Identifier:
10.1055/a-1515-4472
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
4/5
Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Saymatik Web3.0 Wallet